News
Actuate Therapeutics, Inc. (NASDAQ:ACTU) has announced breakthrough results from its Phase 2 trial of elraglusib combined ...
A new clinical trial has shown that combining Gilead Sciences, Inc. (NASDAQ:GILD)’s Trodelvy with Merck & Co., Inc. (NYSE:MRK ...
Xilio Therapeutics, Inc. (NASDAQ:XLO) announced promising updated Phase 2 results for its investigational therapy vilastobart ...
Major spoilers for Mountainhead are ahead! If you have not watched the movie yet, you can stream it with an HBO Max ...
Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...
What if you could live forever, staying healthy and young for centuries? Scientists and tech pioneers now believe this dream ...
Cancer remains a major global health challenge, with genomics playing a critical role in its development and progression. This Research Topic focuses on ...
Jesse Armstrong's HBO film 'Mountainhead' is a modest follow-up to 'Succession.' ...
A training platform integrated with AI can help pathologists identify HER2-low and HER2-ultralow breast cancers with more accuracy, data suggest.
Gene Solutions, a pioneer in AI-driven precision oncology hosted K-CONNECT APAC 2025, a pivotal summit uniting over 100 ...
A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results